Pain in individuals with RASopathies: Prevalence and clinical characterization in a sample of 80 affected patients

Chiara Leoni, Elizabeth Katherine Anna Triumbari, Catello Vollono, Roberta Onesimo, Maria Podagrosi, Valentina Giorgio, Eliza Kuczynska, Stefania Veltri, Marco Tartaglia, Giuseppe Zampino

Research output: Contribution to journalArticle

Abstract

Pain in individuals with RASopathies is a neglected topic in literature. In this article, we assessed prevalence and profile of pain in a sample of 80 individuals affected by RASopathies. The study sample included individuals with Noonan syndrome (N = 42), Costello syndrome (N = 17), and cardio-facio-cutaneous syndrome (N = 21). A set of standardized questionnaires and scales were administered (VAS/numeric scale, r-FLACC, Wang-Baker scale, NPSI, BPI, NCCPC-R) to detect and characterize acute and chronic pain and to study the influence of pain on quality of life (PEDs-QL, SF-36) and sleeping patterns (SDSC); revision of past medical history and multisystemic evaluation was provided. Available clinical data were correlated to the presence of pain. High prevalence of acute (44%) and chronic (61%) pain was documented in the examined sample. Due to age and intellectual disability, acute pain was localized in 18/35 individuals and chronic pain in 33/49. Muscle-skeletal and abdominal pain was more frequently reported. The intensity of acute and chronic pain interfered with daily activities in 1/3 of the sample. Pain negatively impacted on QoL and sleeping patterns. This work documents that pain is highly prevalent in RASopathies. Future studies including subjective and objective measures of pain are required to discriminate a somatosensory abnormality from an abnormal elaboration of painful stimuli at a central level.

Original languageEnglish
Pages (from-to)940-947
Number of pages8
JournalAmerican Journal of Medical Genetics, Part A
Volume179
Issue number6
DOIs
Publication statusPublished - Jun 2019

Fingerprint

Pain
Chronic Pain
Acute Pain
Costello Syndrome
Noonan Syndrome
Myalgia
Intellectual Disability
Abdominal Pain
Quality of Life

Cite this

Pain in individuals with RASopathies : Prevalence and clinical characterization in a sample of 80 affected patients. / Leoni, Chiara; Triumbari, Elizabeth Katherine Anna; Vollono, Catello; Onesimo, Roberta; Podagrosi, Maria; Giorgio, Valentina; Kuczynska, Eliza; Veltri, Stefania; Tartaglia, Marco; Zampino, Giuseppe.

In: American Journal of Medical Genetics, Part A, Vol. 179, No. 6, 06.2019, p. 940-947.

Research output: Contribution to journalArticle

Leoni, Chiara ; Triumbari, Elizabeth Katherine Anna ; Vollono, Catello ; Onesimo, Roberta ; Podagrosi, Maria ; Giorgio, Valentina ; Kuczynska, Eliza ; Veltri, Stefania ; Tartaglia, Marco ; Zampino, Giuseppe. / Pain in individuals with RASopathies : Prevalence and clinical characterization in a sample of 80 affected patients. In: American Journal of Medical Genetics, Part A. 2019 ; Vol. 179, No. 6. pp. 940-947.
@article{c1008f3772684eca9df4ca41b786ca6d,
title = "Pain in individuals with RASopathies: Prevalence and clinical characterization in a sample of 80 affected patients",
abstract = "Pain in individuals with RASopathies is a neglected topic in literature. In this article, we assessed prevalence and profile of pain in a sample of 80 individuals affected by RASopathies. The study sample included individuals with Noonan syndrome (N = 42), Costello syndrome (N = 17), and cardio-facio-cutaneous syndrome (N = 21). A set of standardized questionnaires and scales were administered (VAS/numeric scale, r-FLACC, Wang-Baker scale, NPSI, BPI, NCCPC-R) to detect and characterize acute and chronic pain and to study the influence of pain on quality of life (PEDs-QL, SF-36) and sleeping patterns (SDSC); revision of past medical history and multisystemic evaluation was provided. Available clinical data were correlated to the presence of pain. High prevalence of acute (44{\%}) and chronic (61{\%}) pain was documented in the examined sample. Due to age and intellectual disability, acute pain was localized in 18/35 individuals and chronic pain in 33/49. Muscle-skeletal and abdominal pain was more frequently reported. The intensity of acute and chronic pain interfered with daily activities in 1/3 of the sample. Pain negatively impacted on QoL and sleeping patterns. This work documents that pain is highly prevalent in RASopathies. Future studies including subjective and objective measures of pain are required to discriminate a somatosensory abnormality from an abnormal elaboration of painful stimuli at a central level.",
author = "Chiara Leoni and Triumbari, {Elizabeth Katherine Anna} and Catello Vollono and Roberta Onesimo and Maria Podagrosi and Valentina Giorgio and Eliza Kuczynska and Stefania Veltri and Marco Tartaglia and Giuseppe Zampino",
note = "{\circledC} 2019 Wiley Periodicals, Inc.",
year = "2019",
month = "6",
doi = "10.1002/ajmg.a.61111",
language = "English",
volume = "179",
pages = "940--947",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Pain in individuals with RASopathies

T2 - Prevalence and clinical characterization in a sample of 80 affected patients

AU - Leoni, Chiara

AU - Triumbari, Elizabeth Katherine Anna

AU - Vollono, Catello

AU - Onesimo, Roberta

AU - Podagrosi, Maria

AU - Giorgio, Valentina

AU - Kuczynska, Eliza

AU - Veltri, Stefania

AU - Tartaglia, Marco

AU - Zampino, Giuseppe

N1 - © 2019 Wiley Periodicals, Inc.

PY - 2019/6

Y1 - 2019/6

N2 - Pain in individuals with RASopathies is a neglected topic in literature. In this article, we assessed prevalence and profile of pain in a sample of 80 individuals affected by RASopathies. The study sample included individuals with Noonan syndrome (N = 42), Costello syndrome (N = 17), and cardio-facio-cutaneous syndrome (N = 21). A set of standardized questionnaires and scales were administered (VAS/numeric scale, r-FLACC, Wang-Baker scale, NPSI, BPI, NCCPC-R) to detect and characterize acute and chronic pain and to study the influence of pain on quality of life (PEDs-QL, SF-36) and sleeping patterns (SDSC); revision of past medical history and multisystemic evaluation was provided. Available clinical data were correlated to the presence of pain. High prevalence of acute (44%) and chronic (61%) pain was documented in the examined sample. Due to age and intellectual disability, acute pain was localized in 18/35 individuals and chronic pain in 33/49. Muscle-skeletal and abdominal pain was more frequently reported. The intensity of acute and chronic pain interfered with daily activities in 1/3 of the sample. Pain negatively impacted on QoL and sleeping patterns. This work documents that pain is highly prevalent in RASopathies. Future studies including subjective and objective measures of pain are required to discriminate a somatosensory abnormality from an abnormal elaboration of painful stimuli at a central level.

AB - Pain in individuals with RASopathies is a neglected topic in literature. In this article, we assessed prevalence and profile of pain in a sample of 80 individuals affected by RASopathies. The study sample included individuals with Noonan syndrome (N = 42), Costello syndrome (N = 17), and cardio-facio-cutaneous syndrome (N = 21). A set of standardized questionnaires and scales were administered (VAS/numeric scale, r-FLACC, Wang-Baker scale, NPSI, BPI, NCCPC-R) to detect and characterize acute and chronic pain and to study the influence of pain on quality of life (PEDs-QL, SF-36) and sleeping patterns (SDSC); revision of past medical history and multisystemic evaluation was provided. Available clinical data were correlated to the presence of pain. High prevalence of acute (44%) and chronic (61%) pain was documented in the examined sample. Due to age and intellectual disability, acute pain was localized in 18/35 individuals and chronic pain in 33/49. Muscle-skeletal and abdominal pain was more frequently reported. The intensity of acute and chronic pain interfered with daily activities in 1/3 of the sample. Pain negatively impacted on QoL and sleeping patterns. This work documents that pain is highly prevalent in RASopathies. Future studies including subjective and objective measures of pain are required to discriminate a somatosensory abnormality from an abnormal elaboration of painful stimuli at a central level.

U2 - 10.1002/ajmg.a.61111

DO - 10.1002/ajmg.a.61111

M3 - Article

C2 - 30854769

VL - 179

SP - 940

EP - 947

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 6

ER -